PRP for Androgenetic Alopecia: 43 RCTs in 1,877 Patients Meta-Analysis Validates Hair Density Increase
A large-scale meta-analysis comprehensively examining PRP (autologous platelet-rich plasma) effects in androgenetic alopecia (AGA) treatment was published in Dermatology and Therapy. Across 43 RCTs in 1,877 patients, PRP safely and effectively increased hair density with effects comparable to minoxidil.
Meta-analysis core results
Hair density increase: Activated PRP meaningfully increased hair density vs placebo.
Hair loss reduction: PRP slowed progressive hair loss.
Clinical outcomes and satisfaction: Both patient satisfaction and objective evaluation improved.
Comparison to minoxidil: PRP efficacy comparable to topical minoxidil across selected trials.
Activated vs non-activated: Activated PRP more effective at increasing hair density and minimizing recurrence. Non-activated PRP had higher frequency of adverse effects.
Phase I trial data: A Phase I trial published the same period reported PRP injection group hair count increase 62.4%, hair thickness increase 58.6%.
Side effects: No serious adverse reactions. Only mild side effects in long-term follow-up.
Androgenetic alopecia and PRP mechanism
Androgenetic alopecia: The most common hair loss form. Dihydrotestosterone (DHT) miniaturizes follicles progressively. Affects both sexes.
PRP: Platelets concentrated from the patient’s own blood. Rich in growth factors (PDGF, VEGF, IGF-1, EGF).
Follicle stimulation: Growth factors transition resting follicles to growth phase.
Vascularization: Scalp microvasculature regeneration. Increased follicle nutrition.
Inflammation regulation: Improved follicle environment with chronic inflammation.
Stem cell activation: Stimulation of follicle stem cell differentiation.
Different mechanism from minoxidil (vasodilation). Synergy possible with concurrent use.
Activated vs non-activated PRP
Activated PRP: Platelets activated with calcium chloride or thrombin. Immediate growth factor release. Superior efficacy.
Non-activated PRP: Skip activation step. Natural activation after injection. Some data show higher side effect frequency.
Meta-analysis conclusion: Activated PRP is standard. Non-activated needs additional validation.
Clinical verification: Verify PRP preparation protocol at clinic. Activation, concentration ratio, injection depth.
PRP vs minoxidil comparison
Topical minoxidil 5%: FDA approved. Increased follicle blood flow mechanism. Twice daily application. Effects disappear when discontinued.
PRP: Non-topical. Generally 3~4 sessions at 4~6 week intervals. Then 6 month~1 year maintenance injections.
Efficacy comparison: Comparable in meta-analysis data. Large patient-to-patient response variability.
Combination: PRP + minoxidil possible synergy. Some trials show superiority over either alone.
Cost: Minoxidil low cost. PRP series high cost.
Convenience: Minoxidil daily. PRP requires clinic visits.
Matrix with other options
Oral finasteride/dutasteride: DHT formation inhibition. Strong effect. Male-centered.
Microneedling + PRP: Dermal stimulation synergy. Validated in Phase I trial.
Low-level laser (LLLT): 660nm red light. Home devices available.
Low-dose oral minoxidil: Same period accumulating RCT data. Avoid GI side effects with low dose.
PP405: A new follicle stem cell trial published the same period. New target.
Leqselvi (JAK inhibitor): Same period FDA approval for autoimmune alopecia. Different target from androgenetic.
PRP more effective as part of a matrix than as a standalone option.
Who fits
Early androgenetic alopecia: Stage where follicle miniaturization began but not complete loss. Greatest effect.
Minoxidil side effects/limitations: Populations with topical irritation or insufficient effect.
Female androgenetic alopecia: Populations difficult to use finasteride. Oral androgen blockers risky in pregnancy.
Post-procedure adjunct: PRP supports recovery and graft establishment after hair transplant.
Drug avoidance targeting: Concerns about oral drug side effects, populations preferring natural options.
Who should be careful
Complete follicle loss: No effect on areas where follicles disappeared. Hair transplant is the answer.
Bleeding disorders: PRP is autologous blood. Coagulation evaluation needed.
Active scalp infection: Start after infection recovery.
Pregnancy/breastfeeding: Limited data. Physician evaluation.
Autoimmune alopecia (alopecia areata): Different mechanism. JAK inhibitors and other targets.
Unrealistic expectations: PRP isn’t a magic solution. Gradual improvement is standard.
Series and maintenance
Initial series: 3~4 injections at 4~6 week intervals.
Assessment timing: Effect evaluation after 6 months. Photo comparison, hair thickness measurement.
Maintenance injections: Maintenance injections at 6 month~1 year intervals if effective.
Combination matrix: Topical minoxidil, oral drugs (finasteride, dutasteride), nutritional supplements (biotin, zinc, vitamin D).
Clinic selection: Verify PRP preparation protocol (centrifugation, activation method), practitioner experience, clinical data.
Daily guide
Step 1 — evaluation: Dermatology evaluation. Confirm hair loss progression stage and follicle status. Trichoscopy photo records.
Step 2 — foundation drugs: Topical minoxidil 5% (women 2%) or oral options after physician evaluation. PRP added on the foundation.
Step 3 — PRP series: 3~4 sessions at 4~6 week intervals. Verify clinic protocol.
Step 4 — nutrition: Biotin 5,000~10,000 μg, zinc 15~30 mg, vitamin D 1,000~2,000 IU (25~50 μg), iron (if deficient), protein 1.0~1.2 g/kg/day.
Step 5 — foundation: Scalp hygiene, avoid harsh styling, stress management, sleep hygiene.
Step 6 — assessment and maintenance: Evaluation at 6 months. Maintenance injections if effective. Continue matrix.
Hair loss is a multilayered problem without a single cause or single solution. PRP is one tool in that matrix. Effects accumulate on the foundation of drug therapy, nutrition, and lifestyle.